Bothell-based biopharmaceutical company Athira Pharma Inc. (Nasdaq: ATHA) is paying a $4.1 million fine due to allegations it used doctored research to land a National Institutes of Health grant.

Stressing the importance of integrity in taxpayer-funded biomedical research, the U.S. Department of Justice reported that Athira Pharma Inc. has agreed to pay more than $4 million to resolve False ...

Athira Pharma (ATHA) agreed to pay $4,068,698 to resolve allegations that it violated the False Claims Act by failing to report allegations of research misconduct to the National Institutes of ...

Johnson Ouseph, the accused in the murder of Athira in Kadinamkulam, has been remanded in judicial custody following his arrest early Tuesday. The accused, who was undergoing treatment at the ...

Given this risk, we thought we'd take a look at whether Athira Pharma (NASDAQ:ATHA) shareholders should be worried about its cash burn. In this article, we define cash burn as its annual (negative ...

From what we can see, insiders were net buyers in Athira Pharma, Inc.'s ( NASDAQ:ATHA ) during the past 12 months. That... BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma ...